These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 30637914)

  • 1. Tn antigen promotes human colorectal cancer metastasis via H-Ras mediated epithelial-mesenchymal transition activation.
    Liu Z; Liu J; Dong X; Hu X; Jiang Y; Li L; Du T; Yang L; Wen T; An G; Feng G
    J Cell Mol Med; 2019 Mar; 23(3):2083-2092. PubMed ID: 30637914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cosmc overexpression enhances malignancies in human colon cancer.
    Gao T; Du T; Hu X; Dong X; Li L; Wang Y; Liu J; Liu L; Gu T; Wen T
    J Cell Mol Med; 2020 Jan; 24(1):362-370. PubMed ID: 31633299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T-Synthase Deficiency Enhances Oncogenic Features in Human Colorectal Cancer Cells via Activation of Epithelial-Mesenchymal Transition.
    Dong X; Jiang Y; Liu J; Liu Z; Gao T; An G; Wen T
    Biomed Res Int; 2018; 2018():9532389. PubMed ID: 30035127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant O-glycosylation contributes to tumorigenesis in human colorectal cancer.
    Jiang Y; Liu Z; Xu F; Dong X; Cheng Y; Hu Y; Gao T; Liu J; Yang L; Jia X; Qian H; Wen T; An G
    J Cell Mol Med; 2018 Oct; 22(10):4875-4885. PubMed ID: 29999571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression of Cosmc, T-synthase and mucins in Tn-positive colorectal cancers.
    Sun X; Ju T; Cummings RD
    BMC Cancer; 2018 Aug; 18(1):827. PubMed ID: 30115016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NUBPL, a novel metastasis-related gene, promotes colorectal carcinoma cell motility by inducing epithelial-mesenchymal transition.
    Wang Y; Wu N; Sun D; Sun H; Tong D; Liu D; Pang B; Li S; Wei J; Dai J; Liu Y; Bai J; Geng J; Fu S; Jin Y
    Cancer Sci; 2017 Jun; 108(6):1169-1176. PubMed ID: 28346728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COSMC knockdown mediated aberrant O-glycosylation promotes oncogenic properties in pancreatic cancer.
    Hofmann BT; Schlüter L; Lange P; Mercanoglu B; Ewald F; Fölster A; Picksak AS; Harder S; El Gammal AT; Grupp K; Güngör C; Drenckhan A; Schlüter H; Wagener C; Izbicki JR; Jücker M; Bockhorn M; Wolters-Eisfeld G
    Mol Cancer; 2015 May; 14():109. PubMed ID: 26021314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant Cosmc genes result in Tn antigen expression in human colorectal carcinoma cell line HT-29.
    Yu X; Du Z; Sun X; Shi C; Zhang H; Hu T
    Int J Clin Exp Pathol; 2015; 8(3):2590-602. PubMed ID: 26045765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cosmc transfection decreases malignant behavior of Tn
    Ding R; Hu X; Hu W; Du Z; Huang P; Wang M; Sheng J; Ma Y; Wang A; Luan X; Dong M; Cao Q; Zou Y; Hu T
    Aging (Albany NY); 2021 Oct; 13(19):23393-23406. PubMed ID: 34644263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. OTUB1 promotes metastasis and serves as a marker of poor prognosis in colorectal cancer.
    Zhou Y; Wu J; Fu X; Du W; Zhou L; Meng X; Yu H; Lin J; Ye W; Liu J; Peng H; Liu RY; Pan C; Huang W
    Mol Cancer; 2014 Nov; 13():258. PubMed ID: 25431208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tn antigen promotes breast cancer metastasis via impairment of CASC4.
    Li R; Dong X; Chen S; Tan J; Chen X; Liu J; Wen T; Ru X
    Cell Biol Int; 2023 Nov; 47(11):1854-1867. PubMed ID: 37493437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of Cosmc suppresses cell migration and invasion in different subtypes of breast cancer cells via Tn and T glycans.
    Liu J; Xu F; Li J; Jiang H
    Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32452513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SPP1, analyzed by bioinformatics methods, promotes the metastasis in colorectal cancer by activating EMT pathway.
    Xu C; Sun L; Jiang C; Zhou H; Gu L; Liu Y; Xu Q
    Biomed Pharmacother; 2017 Jul; 91():1167-1177. PubMed ID: 28531945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Side population cells derived from hUCMSCs and hPMSCs could inhibit the malignant behaviors of Tn
    Hu W; Ding R; Wang M; Huang P; Wei X; Hu X; Hu T
    Stem Cell Res Ther; 2023 May; 14(1):145. PubMed ID: 37237420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heat shock protein 90 promotes epithelial to mesenchymal transition, invasion, and migration in colorectal cancer.
    Nagaraju GP; Long TE; Park W; Landry JC; Taliaferro-Smith L; Farris AB; Diaz R; El-Rayes BF
    Mol Carcinog; 2015 Oct; 54(10):1147-58. PubMed ID: 24861206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of the role and mechanism of ARHGAP5-mediated colorectal cancer metastasis.
    Tian T; Chen ZH; Zheng Z; Liu Y; Zhao Q; Liu Y; Qiu H; Long Q; Chen M; Li L; Xie F; Luo G; Wu X; Deng W
    Theranostics; 2020; 10(13):5998-6010. PubMed ID: 32483433
    [No Abstract]   [Full Text] [Related]  

  • 17. Down-regulation of aquaporin 5-mediated epithelial-mesenchymal transition and anti-metastatic effect by natural product Cairicoside E in colorectal cancer.
    Chen C; Ma T; Zhang C; Zhang H; Bai L; Kong L; Luo J
    Mol Carcinog; 2017 Dec; 56(12):2692-2705. PubMed ID: 28833571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic and epigenetic down-regulation of microRNA-212 promotes colorectal tumor metastasis via dysregulation of MnSOD.
    Meng X; Wu J; Pan C; Wang H; Ying X; Zhou Y; Yu H; Zuo Y; Pan Z; Liu RY; Huang W
    Gastroenterology; 2013 Aug; 145(2):426-36.e1-6. PubMed ID: 23583431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA TUG1 promoted KIAA1199 expression via miR-600 to accelerate cell metastasis and epithelial-mesenchymal transition in colorectal cancer.
    Sun J; Hu J; Wang G; Yang Z; Zhao C; Zhang X; Wang J
    J Exp Clin Cancer Res; 2018 May; 37(1):106. PubMed ID: 29776371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-196a-5p promotes metastasis of colorectal cancer via targeting IκBα.
    Xin H; Wang C; Liu Z
    BMC Cancer; 2019 Jan; 19(1):30. PubMed ID: 30621631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.